Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Trkola

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Current Opinion in Microbiology|September 11, 2004
HIV-host interactions: vital to the virus and key to its inhibitionAlexandra Trkola
Nature|April 14, 2019
Conformation of the native HIV-1 envelope protein raises questions for vaccine designAlexandra Trkola
Current Opinion in Microbiology|October 27, 2004
HIV-host interactions: vital to the virus and key to its inhibitionAlexandra Trkola
Nature|October 25, 2014
HIV: Potency needs constancyAlexandra Trkola
STAR Protocols|September 1, 2024
ART-DEX: A novel strategy to monitor broadly neutralizing antibody activity during antiretroviral therapy of HIV-1Magdalena Schwarzmüller, Alexandra Trkola
Swiss Medical Weekly|March 6, 2012
HIV vaccines: an attainable goal?Lucy Reynell, Alexandra Trkola
The Lancet. Infectious Diseases|October 26, 2023
Vaccinating people living with HIV: a fast track to preventive and therapeutic HIV vaccinesAlexandra Trkola, Penny L Moore
Virus Research|October 24, 2015
HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolutionCarsten Magnus, Lucia Reh, Alexandra Trkola
Retrovirology|July 30, 2018
Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?Harini Subbaraman, Merle Schanz, Alexandra Trkola
Current Pharmaceutical Design|December 7, 2010
Therapeutic antibodies in HIV treatment--classical approaches to novel advancesIrene A Abela, Lucy Reynell, Alexandra Trkola
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Current Opinion in Microbiology|September 11, 2004
HIV-host interactions: vital to the virus and key to its inhibitionAlexandra Trkola
Nature|April 14, 2019
Conformation of the native HIV-1 envelope protein raises questions for vaccine designAlexandra Trkola
Current Opinion in Microbiology|October 27, 2004
HIV-host interactions: vital to the virus and key to its inhibitionAlexandra Trkola
Nature|October 25, 2014
HIV: Potency needs constancyAlexandra Trkola
STAR Protocols|September 1, 2024
ART-DEX: A novel strategy to monitor broadly neutralizing antibody activity during antiretroviral therapy of HIV-1Magdalena Schwarzmüller, Alexandra Trkola
Swiss Medical Weekly|March 6, 2012
HIV vaccines: an attainable goal?Lucy Reynell, Alexandra Trkola
The Lancet. Infectious Diseases|October 26, 2023
Vaccinating people living with HIV: a fast track to preventive and therapeutic HIV vaccinesAlexandra Trkola, Penny L Moore
Virus Research|October 24, 2015
HIV-1 resistance to neutralizing antibodies: Determination of antibody concentrations leading to escape mutant evolutionCarsten Magnus, Lucia Reh, Alexandra Trkola
Retrovirology|July 30, 2018
Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?Harini Subbaraman, Merle Schanz, Alexandra Trkola
Current Pharmaceutical Design|December 7, 2010
Therapeutic antibodies in HIV treatment--classical approaches to novel advancesIrene A Abela, Lucy Reynell, Alexandra Trkola
Pageof 15